Change Healthcare (MUN:1CB) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

1CB Overzicht aandelen

Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system.

Over het bedrijf

1CB fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	3/6
Dividenden	0/6

Beloningen

Verhandeld tegen 41.2% onder onze schatting van de reële waarde

De winst zal naar verwachting met 70.43% per jaar groeien

Risicoanalyse

Aandeelhouders zijn het afgelopen jaar verwaterd

Change Healthcare Inc. Concurrenten

Nexus

XTRA:NXU

€925.4m

CompuGroup Medical SE KGaA

XTRA:COP

€717.6m

Carl Zeiss Meditec

XTRA:AFX

€5.8b

Fresenius Medical Care

XTRA:FME

€11.1b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Change Healthcare
Historische aandelenkoersen
Huidige aandelenkoers	US$28.20
52 Week Hoogtepunt	US$28.20
52 Week Laag	US$17.10
Bèta	1.02
11 maand verandering	14.63%
3 maanden verandering	24.78%
1 Jaar Verandering	55.80%
33 jaar verandering	155.81%
5 jaar verandering	n/a
Verandering sinds IPO	118.40%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	1CB	DE Healthcare Services	DE Markt
7D	1.4%	1.4%	1.1%
1Y	55.8%	-37.3%	18.9%

Rendement versus industrie: 1CB overtrof de German Healthcare Services industrie, die het afgelopen jaar een rendement 18.5 % opleverde.

Rendement versus markt: 1CB overtrof de German markt, die het afgelopen jaar een rendement opleverde van 13.8 %.

Prijsvolatiliteit

Is 1CB's price volatile compared to industry and market?
1CB volatility
1CB Average Weekly Movement	2.3%
Healthcare Services Industry Average Movement	5.1%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: 1CB heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 2% ) van 1CB is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2016	14,000	Neil de Crescenzo	www.changehealthcare.com

Change Healthcare Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Change Healthcare zich tot de beurswaarde?
1CB fundamentele statistieken
Marktkapitalisatie	€9.17b
Inkomsten(TTM)	-€78.22m
Inkomsten(TTM)	€3.56b

2.6x

P/S-verhouding

-117.3x

Koers/Winstverhouding

Is 1CB overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1CB resultatenrekening (TTM)
Inkomsten	US$3.50b
Kosten van inkomsten	US$1.64b
Brutowinst	US$1.86b
Overige uitgaven	US$1.93b
Inkomsten	-US$76.95m

Laatst gerapporteerde inkomsten

Jun 30, 2022

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.23
Brutomarge	53.06%
Nettowinstmarge	-2.20%
Schuld/Eigen Vermogen Verhouding	136.5%

Hoe presteerde 1CB op de lange termijn?

Bekijk historische prestaties en vergelijking

1CB Overzicht aandelen

Beloningen

Risicoanalyse

Change Healthcare Inc. Concurrenten

XTRA:NXU

€925.4m

XTRA:COP

€717.6m

XTRA:AFX

€5.8b

XTRA:FME

€11.1b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

IKS Health, Appoints Laura Anderson as Chief Product Officer

Gibbs Law Group Files a Class Action Lawsuit Against Change Healthcare Inc

Change Healthcare Expands Functionality and Drives Industry Transition to Cloud-Based Imaging and Storage

Change Healthcare Inc.(NasdaqGS:CHNG) dropped from S&P TMI Index

Optum, Inc. completed the acquisition of Change Healthcare Inc. (NasdaqGS:CHNG) from Blackstone Capital Partners VI, L.P., other funds managed by The Blackstone Group Inc. (NYSE:BX), Camber Capital Management LLC and others in a merger of equals transaction.

Change Healthcare Inc. Announces Special Cash Dividend, Payable on or About the First Business Day Following the Closing of the Merger

Recent updates

IKS Health, Appoints Laura Anderson as Chief Product Officer

Gibbs Law Group Files a Class Action Lawsuit Against Change Healthcare Inc

Change Healthcare Expands Functionality and Drives Industry Transition to Cloud-Based Imaging and Storage

Change Healthcare Inc.(NasdaqGS:CHNG) dropped from S&P TMI Index

Optum, Inc. completed the acquisition of Change Healthcare Inc. (NasdaqGS:CHNG) from Blackstone Capital Partners VI, L.P., other funds managed by The Blackstone Group Inc. (NYSE:BX), Camber Capital Management LLC and others in a merger of equals transaction.

Change Healthcare Inc. Announces Special Cash Dividend, Payable on or About the First Business Day Following the Closing of the Merger

Forecast breakeven date pushed back to 2025

Insufficient new directors

Forecast breakeven date moved forward to 2023

First quarter 2023 earnings released: US$0.071 loss per share (vs US$0.011 loss in 1Q 2022)

Change Healthcare Inc. to Report Q1, 2023 Results on Aug 03, 2022

Change Healthcare in Collaboration with Luma Health Launches Patient Engagement

Forecast breakeven date pushed back to 2024

Full year 2022 earnings released: US$0.18 loss per share (vs US$0.35 loss in FY 2021)

Change Healthcare Inc. to Report Q4, 2022 Results on May 25, 2022

Funds managed by TPG Capital, L.P. entered into an agreement to acquire the claims editing business of Change Healthcare Inc. (NasdaqGS:CHNG) for $2.2 billion.

Change Healthcare Launches InterQual 2022, Delivering the Latest Evidence-Based Criteria and Technology to Optimize Clinical Decision Support

Change Healthcare Inc. Announces Management Changes

Change Healthcare Inc. Pays Special Cash Dividend

Change Healthcare Inc., Annual General Meeting, Mar 29, 2022

Third quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Change Healthcare Reportedly Considering Selling Some Assets Including ClaimsXten Business

Insider recently sold €83k worth of stock

Insider recently sold €165k worth of stock

Second quarter 2022 earnings released: US$0.12 loss per share (vs US$0.13 loss in 2Q 2021)

Forecast breakeven pushed back to 2023

Change Healthcare Releases End-To-End, Cloud-Native Solution for Medical Imaging

First quarter 2022 earnings released: US$0.012 loss per share (vs US$0.18 loss in 1Q 2021)

Change Healthcare Inc.(NasdaqGS:CHNG) dropped from Russell 2500 Growth Index

Change Healthcare Enhances Developers’ Ability to Scale API Use and Comply with Pending CMS Interoperability Rule

Change Healthcare Launches No-Fee, Privacy-Protecting, Portable Vaccination Record

Change Healthcare in Collaboration with AWS Announces New Data Science as A Service Offering to Drive Improved Outcomes and Healthcare Economics for Vulnerable Health Communities

New 90-day high: €19.80

Change Healthcare Inc. to Report Q3, 2021 Results on Feb 03, 2021

New 90-day high: €19.50

New 90-day high: €15.40

Change Healthcare Continues to Lead the Industry in Taking Enterprise Imaging to the Cloud

New 90-day high: €14.50

New 90-day high: €13.14

Change Healthcare Announces A New Solution That Makes It Easier for Consumers to Get COVID-19 Testing in Their Local Pharmacies

Change Healthcare Inc. (NasdaqGS:CHNG) acquired Nucleus.io from NucleusHealth, LLC.

Change Healthcare Inc. (NasdaqGS:CHNG) acquired PROMETHEUS Analytics from Altarum Institute.

Change Healthcare Inc. Not Provides Guidance for the Year 2021

Change Healthcare Inc. (NasdaqGS:CHNG) acquired eRx Network, LLC for approximately $210 million.

Change Healthcare Inc. to Report Q1, 2021 Results on Aug 05, 2020

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Change Healthcare Inc. Samenvatting

2.6x

-117.3x

Inkomsten en omzet